- Meeting abstract
- Open Access
Is S-upar level correlated to the length of hospitalization
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine volume 23, Article number: A32 (2015)
The purpose of this study is to investigate if S-uPAR correlates with expected length of patients' hospitalization. This could be useful in emergency medicine, due to the acute departments treating patients hospitalized for 48 hours or less. S-uPAR (Urokinase Plasminogen Activator, CD87) is a potential biomarker thought to be related to inflammatory immune cell activation. It is expressed on various immune cells including neutrophils, monocytes, macrophages, and lymphocytes. Upon inflammation, it is cleaved from the cell surface and released into serum. S-uPAR has shown prognostic and clinical value in the triage of patients as described in an editorial comment in the Journal of Internal Medicine 2012 .
It is a follow-up study including 60 unselected patients (n = 60) above 60 years of age and is the first sample of a larger study including 500 patients. Blood samples in this study have been collected from patients at admission. The samples were frozen afterwards and the patients have been examined retrospectively by physicians and stratified into groups: hospitalized < 24 hours, 24-72 hours, and > 72 hours.
The mean S-uPAR value for the < 24h group (n = 14) was 2.75 (1.5 - 24.3). This compared to the 24-72h group (n = 13) with a mean value of 4.3 (3.4-16.9) and the > 72h group (n = 29) with a mean value of 4.1 (0.8-18.7).
Patients hospitalized < 24h have lower S-uPAR values compared to patients hospitalized >24h. Preliminary findings of the study show no correlation between the patients S-uPAR values and the length of hospitalization. When all 500 patients have been included, further analysis will be conducted, including analysis of patients presenting very high and very low S-uPAR values to exclude those with known confounders.
Koch A, Tacke F: Risk stratification and triage in the emergency department: has this become 'suPAR' easy?. Journal of Internal Medicine. 2012, 272 (3): 243-246. 10.1111/j.1365-2796.2012.02568.x.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Baymler, E.K., Jensen, I.K., Danielsen, M.B. et al. Is S-upar level correlated to the length of hospitalization. Scand J Trauma Resusc Emerg Med 23 (Suppl 1), A32 (2015). https://doi.org/10.1186/1757-7241-23-S1-A32
- Public Health
- Internal Medicine
- Blood Sample
- Cell Surface
- Immune Cell